Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy.

Lin X, Finkelstein SD, Zhu B, Ujevich BJ, Silverman JF.

Cancer. 2009 Feb 25;117(1):57-66. doi: 10.1002/cncy.20010.

PMID:
19347831
[PubMed - indexed for MEDLINE]
Free Article
2.

Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.

Cai JC, Liu D, Liu KH, Zhang HP, Zhong S, Xia NS.

World J Gastroenterol. 2008 Jul 7;14(25):4070-6.

PMID:
18609693
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Molecular markers and genetics in cancer development.

Hormi-Carver K, Souza RF.

Surg Oncol Clin N Am. 2009 Jul;18(3):453-67. doi: 10.1016/j.soc.2009.03.002. Review.

PMID:
19500736
[PubMed - indexed for MEDLINE]
4.

Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?

Ortner MA.

Curr Gastroenterol Rep. 2001 Oct;3(5):371-4. No abstract available.

PMID:
11560793
[PubMed - indexed for MEDLINE]
5.

Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.

Klump B, Hsieh CJ, Holzmann K, Borchard F, Gaco V, Greschniok A, Eckardt VF, Bettendorf U, Gregor M, Porschen R.

Z Gastroenterol. 1999 Oct;37(10):1005-11.

PMID:
10549095
[PubMed - indexed for MEDLINE]
6.

Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.

Shaheen NJ, Spechler SJ.

Endoscopy. 2008 Dec;40(12):994-9. doi: 10.1055/s-2008-1077785. Epub 2008 Dec 8. Review. No abstract available.

PMID:
19065482
[PubMed - indexed for MEDLINE]
7.

Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.

Werther M, Saure C, Pahl R, Schorr F, Rüschoff J, Alles JU, Heinmöller E.

Pathol Res Pract. 2008;204(5):285-94. doi: 10.1016/j.prp.2007.12.011. Epub 2008 Mar 11.

PMID:
18337019
[PubMed - indexed for MEDLINE]
8.

The diagnosis and management of Barrett's esophagus.

DeMeester SR, DeMeester TR.

Adv Surg. 1999;33:29-68. Review.

PMID:
10572561
[PubMed - indexed for MEDLINE]
9.

Early Barrett's carcinoma of the esophagus.

Hölscher AH, Vallböhmer D, Bollschweiler E.

Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):347-54. Review. No abstract available.

PMID:
19131920
[PubMed - indexed for MEDLINE]
Free Article
10.

Familial Barrett's adenocarcinoma.

Melzer E, Shtoyerman R, Appelman Z, Kashtan H.

Am J Gastroenterol. 2006 Mar;101(3):677. No abstract available.

PMID:
16542304
[PubMed - indexed for MEDLINE]
11.

Cryotherapy for the prevention and treatment of esophageal cancer: when does efficacy equal success?

Hernandez LV, Eisen GM.

Gastrointest Endosc. 2010 Apr;71(4):694-6. doi: 10.1016/j.gie.2010.02.026. No abstract available.

PMID:
20363411
[PubMed - indexed for MEDLINE]
12.

[Early esophageal carcinoma: diagnosis and endoscopic therapy].

Ell C.

Z Gastroenterol. 2002 Dec;40 Suppl 2:12-4. German. No abstract available.

PMID:
12466997
[PubMed - indexed for MEDLINE]
13.

Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.

Walch A, Mueller J, Höfler H, Werner M.

J Natl Cancer Inst. 2000 Jul 19;92(14):1182-3. No abstract available.

PMID:
10904093
[PubMed - indexed for MEDLINE]
Free Article
14.

[Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].

Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E.

Pol Merkur Lekarski. 2009 May;26(155):385-9. Polish.

PMID:
19606680
[PubMed - indexed for MEDLINE]
15.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
[PubMed - indexed for MEDLINE]
16.

An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.

Lu D, Vohra P, Chu PG, Woda B, Rock KL, Jiang Z.

Am J Surg Pathol. 2009 Apr;33(4):521-5. doi: 10.1097/PAS.0b013e31818aada9.

PMID:
19047899
[PubMed - indexed for MEDLINE]
17.

[No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].

Schilling D, Riemann JF.

MMW Fortschr Med. 2002 Jul 11;144(27-28):40-1. German. No abstract available.

PMID:
12198878
[PubMed - indexed for MEDLINE]
18.

[Topic Complex VI: Barrett esophagus].

Messmann H, Ell C, Fein M, Kiesslich R, Ortner M, Porschen R, Stolte M.

Z Gastroenterol. 2005 Feb;43(2):184-90. Review. German. No abstract available.

PMID:
15700212
[PubMed - indexed for MEDLINE]
19.

Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.

Adams L, Roth MJ, Abnet CC, Dawsey SP, Qiao YL, Wang GQ, Wei WQ, Lu N, Dawsey SM, Woodson K.

Cancer Prev Res (Phila). 2008 Oct;1(5):357-61. doi: 10.1158/1940-6207.CAPR-08-0061.

PMID:
19137073
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.

Bektas N, Donner A, Wirtz C, Heep H, Gabbert HE, Sarbia M.

Am J Clin Pathol. 2000 Dec;114(6):890-5.

PMID:
11338478
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk